EMA — authorised 18 March 2008
- Marketing authorisation holder: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- Status: approved
EMA authorised Pradaxa on 18 March 2008
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 18 March 2008.
BOEHRINGER INGELHEIM INTERNATIONAL GMBH holds the EU marketing authorisation.